Snowball logo
logo
LGND_logo

Ligand Pharmaceuticals Incorporated

LGND β€’ NASDAQ
$281.72+$1.54Β  (0.55%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
241.5196.2131.3167.1268.1290.5
COGS
62.1852.8335.0511.076.58754.1205
Gross Profit
179.4143.496.27156.1261.5289.6
Operating Expenses & Income
Operating Income
103.93.03711.94(22.61)47.2100.9
Total Operating Expenses
75.52140.484.32178.7214.3188.7
R&D Expenses
32.136.0824.5421.4381.1841.35
Selling General & Admin Expenses
46.7970.0652.7978.6592.45103.4
Earnings from Continuing Operations
Interest Expense
(19.62)(1.799)(0.656)(3.037)(4.715)(6.19)
Interest Income
0.8862.0467.0418.05513.6624.22
Income Tax Expense
(4.148)41.239.8416.5534.5140.74
Net Income
Net Income
57.14(33.36)52.15(4.032)124.5197.2
Supplemental
EBIT
91.8237.8164.325.555159239.7
EBITDA
142.881.2100.840.79192.7273.7
In millions of USD, except % and values per 1 share